Crónicas de autores

Teresa Acosta Almeida *

Autor invitado por SIIC


EXPRESIÓN ANORMAL DEL SISTEMA NKB/NK3 EN LEIOMIOMAS UTERINOS

El miometrio normal de la mujer expresa el receptor NK3 así como el péptido NKB, contribuyendo a la regulación normal de este órgano, mientras que en los miomas el sistema NK3R/NKB está aumentado, pudiendo contribuir a las menorragias que experimentan frecuentemente las mujeres sintomáticas así como a la proliferación tumoral.

*Teresa Acosta Almeida
describe para SIIC los aspectos relevantes de su trabajo
DIFFERENTIALLY REGULATED EXPRESSION OF NEUROKININ B (NKB)/NK3 RECEPTOR SYSTEM IN UTERINE LEIOMYOMATA
Human Reproduction,
28(7):1799-1808 Jul, 2013

Esta revista, clasificada por SIIC Data Bases, integra el acervo bibliográfico
de la Biblioteca Biomédica (BB) SIIC.

Institución principal de la investigación
*Universidad de la Laguna, La Laguna, España
Imprimir nota
Referencias bibliográficas
Almeida TA, Rojo J, Nieto PM, Pinto FM, Hernández M, Martin JD, Candenas ML. Tachykinins and tachykinin receptors: structure and activity relationships. Curr Med Chem 2004;11:2045–2081.

Topaloglu AK, Reimann F, Guclu M, Yalin AS, Kotan LD, Porter KM, Serin A, Mungan NO, Cook JR, Ozbek MN. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for neurokinin B in the central control of reproduction. Nat Genet 2009;41:354–358.

Semple RK, Topaloglu AK. Neurokinin B and its receptor in hypogonadotropic hypogonadism. Front Horm Res 2010;39:1333–1341.

Patak E, Candenas ML, Pennefather JN, Ziccone S, Lilley A, Martin JD, Flores C, Mantecon AG, Story ME, Pinto FM. Tachykinins and tachykinin receptors in human uterus. Br J Pharmacol 2003;139:523–532.

Pennefather JN, Lecci A, Candenas ML, Patak E, Pinto FM, Maggi CA. Tachykinins and tachykinin receptors: a growing family. Life Sci 2004a;74:1445–1463.

Pennefather JN, Patak E, Pinto FM, Candenas ML. Mammalian tachykinins and uterine smooth muscle: the challenge escalates. Eur J Pharmacol 2004b;500:15–26.

Levy G, Hill MJ, Beall S, Zarek SM, Segars JH, Catherino WH. Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances. J Assist Reprod Genet 2012;29:703–712.

Horcajadas JA, Goyri E, Higón MA, Martínez-Conejero JA, Gambadauro P,García G, Meseguer M, Simón C, Pellicer A. Endometrial receptivity and implantation are not affected by the presence of uterine intramural leiomyomas: a clinical and functional genomics analysis. J Clin Endocrinol Metab 2008;93:3490–3498.

Stewart EA, Nowak RA. Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era. Hum Reprod Update 1996;2:295–306.

Sankaran S, Manyonda IT. Medical management of fibroids. Best Pract Res ClinObstet 2008;22:655–676.

Cejudo Roman A, Pinto FM, Dorta I, Almeida TA, Hernánndez M, llanes M, Tena-Sempere M, Candenas ML. Analysis of the expression of neurokinin B, kisspeptin, and their cognate receptors NK3R and KISS1R in the human female genital tract. Fetil Steril 2012;97:1213–1219.

Lessard A, Campos MM, Neugebauer W, Couture R. Implication of nigral tachykinin NK3 receptors in the maintenance of hypertension in spontaneously hypertensive rats: a pharmacologic and autoradiographic study. Br J Pharmacol 2003;138:554–563.

Mastrangelo D, Mathison R, Huggel HJ, Dion S, D’Orlenas-Juste P,Rhaleb NE, Drapeau G, Rovero P, Regoli D. The rat isolated portal vein: a preparation sensitive to neurokinins, particularly neurokinin B. Eur JPharmacol 1987;134:321–326.

Wareing M, Bhatti H, O’hara M, Kenny L, WarrenAY, Taggart MJ, Baker PN. Vasoactive effects of neurokinin B on human blood vessels. Am J Obstet Gynecol 2003;188:196–202.

Laliberte C, DiMarzo L, Morrish DW, Kaufman S. Neurokinin B causes concentration-dependent relaxation of isolated human placental resistance vessels. Regul Pept 2004;117:123–126.

Brownbill P, Bell NJ,Woods RJ, Lowry PJ, Page NM, Sibely CP. Neurokinin B is a paracrine vasodilator in the human fetal placental circulation. J ClinEndocrinol Metab 2003;88:2164–2170.


ua40317